Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea
| dc.contributor.author | Uz U. | |
| dc.contributor.author | Günhan K. | |
| dc.contributor.author | Pabuşcu Y. | |
| dc.contributor.author | Mutlu S. | |
| dc.contributor.author | Kamiloǧlu U. | |
| dc.date.accessioned | 2025-04-10T11:03:31Z | |
| dc.date.available | 2025-04-10T11:03:31Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Coronavirus disease 2019 (COVID-19) is a highly contagious disease that has reached pandemic status. The diagnosis of COVID-19 is made using the polymerase chain reaction test to evaluate a swab taken from the naso/oro-pharyngeal area. Since COVID-19 is still a pandemic, it is thought that the use of this diagnostic test will be on the agenda for a while. A patient with COVID-19 symptoms presented with unilateral cerebrospinal fluid rhinorrhea after a nasopharyngeal swab test. Although nasopharyngeal swabs are taken very frequently, the complication rate is very low. However, life-threatening complications can be observed on rare occasions, and care should be taken. © 2023 Lippincott Williams and Wilkins. All rights reserved. | |
| dc.identifier.DOI-ID | 10.1097/SCS.0000000000009285 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/44786 | |
| dc.publisher | Lippincott Williams and Wilkins | |
| dc.title | Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea | |
| dc.type | Article |